Proprietary Chinese Medicines

Proprietary Chinese Medicines

YICHANG, CHINA - JULY 18, 2023 - Citizens display purchased proprietary Chinese medicines in Yichang, Hubei province, China, July 18, 2023. The "2022 National Traditional Chinese Medicine Supervision Blue Book" issued under the guidance of the State Drug Administration was released. According to the blue book, a total of 47 varieties and 5,805 batches of proprietary Chinese medicines will be tested by the state in 2022, with a passing rate of 99.3%. According to the 2022 National Traditional Chinese Medicine Supervision Blue Book, as of May 2023, China has about 2,400 proprietary Chinese medicine manufacturers, with about 9,000 traditional Chinese medicine varieties and about 57,000 effective approval numbers, basically meeting the public's clinical drug needs.

  • Product Code
  • ILEA001537577
  • Registered date
  • 2023/7/18 00:00:00
  • Credit
  • CFOTO / Kyodo News Images
  • Media source
  • CFOTO
  • Media size
  • 4864 × 3522 pixel
  • Resolution
  • 350 dpi
  • Deployment size
  • 2.74(MB)*
  • Special instruction
  • China Out
    **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Proprietary Chinese Medicines

    Proprietary Chinese Medicines

    YICHANG, CHINA - JULY 18, 2023 - Citizens display purchased proprietary Chinese medicines in Yichang, Hubei province, China, July 18, 2023. The "2022 National Traditional Chinese Medicine Supervision Blue Book" issued under the guidance of the State Drug Administration was released. According to the blue book, a total of 47 varieties and 5,805 batches of proprietary Chinese medicines will be tested by the state in 2022, with a passing rate of 99.3%. According to the 2022 National Traditional Chinese Medicine Supervision Blue Book, as of May 2023, China has about 2,400 proprietary Chinese medicine manufacturers, with about 9,000 traditional Chinese medicine varieties and about 57,000 effective approval numbers, basically meeting the public's clinical drug needs.
      Proprietary Chinese Medicines

      Proprietary Chinese Medicines

      YICHANG, CHINA - JULY 18, 2023 - Citizens display purchased proprietary Chinese medicines in Yichang, Hubei province, China, July 18, 2023. The "2022 National Traditional Chinese Medicine Supervision Blue Book" issued under the guidance of the State Drug Administration was released. According to the blue book, a total of 47 varieties and 5,805 batches of proprietary Chinese medicines will be tested by the state in 2022, with a passing rate of 99.3%. According to the 2022 National Traditional Chinese Medicine Supervision Blue Book, as of May 2023, China has about 2,400 proprietary Chinese medicine manufacturers, with about 9,000 traditional Chinese medicine varieties and about 57,000 effective approval numbers, basically meeting the public's clinical drug needs.
        Proprietary Chinese Medicines

        Proprietary Chinese Medicines

        YICHANG, CHINA - JULY 18, 2023 - Citizens display purchased proprietary Chinese medicines in Yichang, Hubei province, China, July 18, 2023. The "2022 National Traditional Chinese Medicine Supervision Blue Book" issued under the guidance of the State Drug Administration was released. According to the blue book, a total of 47 varieties and 5,805 batches of proprietary Chinese medicines will be tested by the state in 2022, with a passing rate of 99.3%. According to the 2022 National Traditional Chinese Medicine Supervision Blue Book, as of May 2023, China has about 2,400 proprietary Chinese medicine manufacturers, with about 9,000 traditional Chinese medicine varieties and about 57,000 effective approval numbers, basically meeting the public's clinical drug needs.
          Proprietary Chinese Medicines

          Proprietary Chinese Medicines

          YICHANG, CHINA - JULY 18, 2023 - Citizens display purchased proprietary Chinese medicines in Yichang, Hubei province, China, July 18, 2023. The "2022 National Traditional Chinese Medicine Supervision Blue Book" issued under the guidance of the State Drug Administration was released. According to the blue book, a total of 47 varieties and 5,805 batches of proprietary Chinese medicines will be tested by the state in 2022, with a passing rate of 99.3%. According to the 2022 National Traditional Chinese Medicine Supervision Blue Book, as of May 2023, China has about 2,400 proprietary Chinese medicine manufacturers, with about 9,000 traditional Chinese medicine varieties and about 57,000 effective approval numbers, basically meeting the public's clinical drug needs.
            Proprietary Chinese Medicines

            Proprietary Chinese Medicines

            YICHANG, CHINA - JULY 18, 2023 - Citizens display purchased proprietary Chinese medicines in Yichang, Hubei province, China, July 18, 2023. The "2022 National Traditional Chinese Medicine Supervision Blue Book" issued under the guidance of the State Drug Administration was released. According to the blue book, a total of 47 varieties and 5,805 batches of proprietary Chinese medicines will be tested by the state in 2022, with a passing rate of 99.3%. According to the 2022 National Traditional Chinese Medicine Supervision Blue Book, as of May 2023, China has about 2,400 proprietary Chinese medicine manufacturers, with about 9,000 traditional Chinese medicine varieties and about 57,000 effective approval numbers, basically meeting the public's clinical drug needs.
              Proprietary Chinese Medicines

              Proprietary Chinese Medicines

              YICHANG, CHINA - JULY 18, 2023 - Citizens display purchased proprietary Chinese medicines in Yichang, Hubei province, China, July 18, 2023. The "2022 National Traditional Chinese Medicine Supervision Blue Book" issued under the guidance of the State Drug Administration was released. According to the blue book, a total of 47 varieties and 5,805 batches of proprietary Chinese medicines will be tested by the state in 2022, with a passing rate of 99.3%. According to the 2022 National Traditional Chinese Medicine Supervision Blue Book, as of May 2023, China has about 2,400 proprietary Chinese medicine manufacturers, with about 9,000 traditional Chinese medicine varieties and about 57,000 effective approval numbers, basically meeting the public's clinical drug needs.